# Ascenta Capital

Ascenta Capital is a Private Equity based in Wilmington, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Wilmington, United States
- **Region:** North America
- **Address:** Wilmington, United States
- **Founded:** 2023
- **Assets under management:** Undisclosed
- **Website:** ascentacap.com
- **LinkedIn:** https://www.linkedin.com/company/ascenta-capital

## Regulatory record

- **CRD number:** 327650
- **SEC file number:** 802-128623
- **Registration status:** Exempt Reporting Adviser — not registered with the SEC
- **Latest Form ADV filing:** 2026-03-31T05:00:00.000Z
- **Reports private funds:** Yes
- **Private funds reported:** 0

## About

Ascenta Capital is a biotech venture capital firm focused on drug development. It helps innovative companies grow from their scientific foundations to advance the clinical development of meaningful medicines for patients. The firm makes concentrated investments and works in collaboration to support management teams with strategic and operational experience.

## Sectors

- Biotech venture capital and drug development

## People

- Evan Rachlin — MD — Co-Founder and Managing Partner
- Lorence Kim — MD — Co-Founder and Advisory Partner
- Paul Deutsch — MD / PhD — Advisory Partner
- Michael Rosenblatt — MD — Advisory Partner
- Jeff Chodakewitz — MD — Advisory Partner
- Daniel Bloomfield — MD — Advisory Partner
- John Gutierrez — MD — Principal
- Leighanne Oh — MS — Vice President

## Related profiles

- [Ascensus Investment Advisors](https://altss.com/profile/ascensus-investment-advisors)
- [Ascent Africa](https://altss.com/profile/ascent-africa)

---

Updated: 2026-08-11T15:06:04.815Z

Canonical page: https://altss.com/profile/ascenta-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology